ADMA BIOLOGICS, INC. Restricted Cash, Current
ADMA BIOLOGICS, INC. (ADMA) had Restricted Cash, Current of $0 as of 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2019-03-13
- 2018-12-31: Restricted Cash, Current $0.00.
- 2018-09-30: Restricted Cash, Current $0.00.
- 2017-12-31: Restricted Cash, Current $1.50M.
- 2016-12-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2017-12-31 | $1.50M 10-K · filed 2019-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |